MuscleBlaze Biozyme Daily Multivitamin for men is packed in a thirty-sachet set that contains three tablets per sachet. Ideal for advanced gym-goer, MB Biozyme Daily Multivitamin is what you need to reach those levels of extraordinary. Bundled with essential nutrients, potent herbal ingredients, and key stimulating ingredients, these multivitamin tablets help ensure that you supplement your diet with the right energy and performance. In addition to helping you achieve great energy levels and results, these multivitamin tablets also support your immune system. EAF present in this multivitamin for men helps increase the protein absorbing capacity of your body by 50% and actively contributes to improving your workouts and increasing those gains. The vitamins and minerals blend, joint blend, and t-booster blend help in the optimum functioning of the body, support mobility and flexibility of the joints, and muscle mass gain.
MUSCLEBLAZE Biozyme Daily Multivitamin for Men, 5-in-1 Supplement (90 Tablets)
Original price was: ₹1,299.00.₹899.00Current price is: ₹899.00.
+ Free ShippingMuscleBlaze Biozyme Daily Multivitamin for men is packed in a thirty-sachet set that contains three tablets per sachet. Ideal for advanced gym-goer, MB Biozyme Daily Multivitamin is what you need to reach those levels of extraordinary. Bundled with essential nutrients, potent herbal ingredients, and key stimulating ingredients, these multivitamin tablets help ensure that you supplement your diet with the right energy and performance. In addition to helping you achieve great energy levels and results, these multivitamin tablets also support your immune system. EAF present in this multivitamin for men helps increase the protein absorbing capacity of your body by 50% and actively contributes to improving your workouts and increasing those gains. The vitamins and minerals blend, joint blend, and t-booster blend help in the optimum functioning of the body, support mobility and flexibility of the joints, and muscle mass gain.
Reviews
There are no reviews yet.